Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 41 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 9115193

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  2. US 9115120

    Heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  3. US 9103826

    Methods and biomarkers for the detection of dengue hemorrhagic fever

    The Board of Regents of the University of Texas System · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  4. US 9101637

    Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity

    The Board of Regents of the University of Texas System · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  5. US 9102940

    RNAi modulation of SCAP and therapeutic uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  6. US 9095572

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  7. US 9095571

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  8. US 9095558

    Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

    The Board of Regents of the University of Texas System · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  9. US 9096830

    Multi-layered hydrogel constructs and associated methods

    The Board of Regents of the University of Texas System · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  10. US 9096499

    Compounds for treatment of cell proliferative diseases

    The Board of Regents of the University of Texas System · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  11. US 9078441

    Antimicrobial flush solutions

    The Board of Regents of the University of Texas System · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  12. US 9079944

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  13. US 9078919

    Micro-RNAs of the miR-15 family modulate cardiomyocyte survival and cardiac repair

    The Board of Regents of the University of Texas System · Granted Jul 14, 2015 · Expires Jul 9, 2035

    granted

  14. US 9073851

    Compositions and methods for treating cancer

    The Board of Regents of the University of Texas System · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  15. US 9072765

    Identification of micro-RNAs involved in post-myocardial infarction remodeling and heart failure

    The Board of Regents of the University of Texas System · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  16. US 9072705

    Oligo-benzamide compounds and their use in treating cancers

    The Board of Regents of the University of Texas System · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  17. US 9068007

    Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease

    The Board of Regents of the University of Texas System · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  18. US 9061027

    Enhanced delivery of drug compositions to treat life threatening infections

    The Board of Regents of the University of Texas System · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  19. US 9061055

    Oncolytic adenovirus armed with therapeutic genes

    The Board of Regents of the University of Texas System · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  20. US 9050378

    N2S2 chelate-targeting ligand conjugates

    The Board of Regents of the University of Texas System · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted

  21. US 9044391

    Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery

    The Board of Regents of the University of Texas System · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  22. US 9045416

    WNT protein signalling inhibitors

    The Board of Regents of the University of Texas System · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  23. US 9040157

    Hollow nanoparticles and nanocomposites and methods of making hollow nanoparticles and nanocomposites

    The Board of Regents of the University of Texas System · Granted May 26, 2015 · Expires May 21, 2035

    granted

  24. US 9040567

    BAX agonist, compositions, and methods related thereto

    The Board of Regents of the University of Texas System · Granted May 26, 2015 · Expires May 21, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.